On March 13, 2025, the US stock market closed with mixed results. The Dow Jones Industrial Average fell by 0.14%, the S&P 500 Index decreased by 0.09%, and the Nasdaq Composite Index dropped by 0.28%.

In the sector performance, the US cybersecurity stocks experienced significant declines. Cloudflare, Inc. fell by 4.85%, CrowdStrike Holdings, Inc. dropped by 3.50%, and Zscaler, Inc. decreased by 3.00%. On the other hand, the US gold stocks saw notable gains. Newmont Mining rose by 4.63%, Eldorado increased by 4.44%, and Gold Fields climbed by 2.82%.

NVIDIA saw a slight decline of 0.03%. Concerns were raised about its future earnings growth due to its lower stock valuation compared to other companies. The chip maker reported a significant increase in earnings for fiscal 2025, but this growth could be at risk if competitors like Advanced Micro Devices gain a larger market share or if spending on data centers slows down.

Tesla Motors fell by 2.99%. The stock experienced a decline despite the company's recent activities, including the unveiling of refreshed versions of its G6 and G9 SUVs at lower prices.

Adobe plunged by 13.85%. The company reported strong earnings but saw a decline in shares due to disappointing guidance. Multiple analysts, including BMO Capital, Mizuho, UBS, Keybanc, Evercore ISI Group, and Stifel, have cut their price targets for Adobe, contributing to the negative sentiment.

Intel surged by 14.60%. The company announced the appointment of Lip-Bu Tan as its new CEO, leading to a significant increase in the company's stock price. Tan, a former board member and successful CEO of Cadence Design Systems, is expected to bring about a turnaround for Intel. Analysts have upgraded their outlook on Intel and increased their price target for the stock.

UiPath dropped by 15.72%. The company faced multiple price target cuts from analysts, including Mizuho, Wells Fargo, Evercore ISI Group, Canaccord Genuity, and RBC Capital, which contributed to the sharp decline in its stock price.

Goldman Sachs fell by 2.03%. Morgan Stanley maintained an overweight rating on Goldman Sachs but cut its price target from $782.00/share to $659.00/share, leading to a decrease in the stock price.

Riot Platforms declined by 6.88%. JP Morgan cut the price target for Riot Platforms from $16.00 per share to $13.00 per share, suggesting a decrease in the expected value of the stock.

Dogwood Therapeutics Inc. plummeted by 27.76%. The company announced a registered direct offering of common stock priced at-the-market under Nasdaq rules, valued at $4.8 million. The proceeds from the financing will fund operations through Q1 2026, and the company plans to announce interim data from its ongoing Halneuron Phase 2b chemotherapy-induced neuropathic pain trial in Q4 2025.